Optimal treatment for recurrent high-grade glioma continues to evolve. Currently, however,
there is no consensus in the literature on the role of reoperation in the management of these …

Background: Glioblastoma multiforme (GBM) inevitably recurs, but no standard regimen has
been established for recurrent patients. Reoperation at recurrence alleviates mass effects …

Optimal treatment for recurrent glioblastoma continues to evolve. Currently, however, there
is no consensus in the literature on the role of reoperation in the management of these …

Over the last quarter century there has been significant progress toward identifying certain
characteristics and patterns in GBM patients to predict survival times and outcomes. We …

Introduction This study aimed to report the characteristics, prognostic factors and treatment
outcome of 223 patients with glioblastoma multiforme (GBM). Subjects and method This …

Glioblastoma is an aggressive and fast‐growing brain tumor with poor prognosis. Predicting
the expected survival of patients with glioblastoma is a key task for efficient treatment and …

Objective: A long-lasting concern has prevailed for the identification of predictive biomarkers
for high-grade gliomas (HGGs) using MRI. However, a consensus of which imaging …

Objectives Glioblastoma (GB) contains diverse histologic regions. Apparent diffusion
coefficient (ADC) values are surrogates for the degree of number of cells within the tumour …

Certification systems play an important role in any market that is burdened with a high
degree of information asymmetry and quality uncertainty. Thus, producers and exporters of …

Objective This study aimed to develop a radiomics model to predict early recurrence (< 1
year) in grade II glioma after the first resection. Methods The pathological, clinical, and …